cipramil (celexa) stories,, lundbeck, Newspaper and internet articles, psychiatry

The Lundbeck merry-go-round.

IFMAD
Click to view brochure

This November IFMAD are holding a symposium in Monte Carlo which is sponsored by an unrestricted grant from Lundbeck pharmaceuticals.

IFMAD is an abbreviation for ‘International Forum on Mood and Anxiety Disorders’ – an unfortunate abbreviation it has to be said. Their website is also sponsored by Lundbeck Pharmaceuticals.

According to their ‘Lundbeck sponsored’ website, IFMAD was founded in 2000 by ‘Professor Siegfried Kasper and Professor Stuart Montgomery’ and supported by a scientific committee from around the world.

So what, you may ask? What’s another pharma funded symposium? Why does it matter that the brochure has a huge advert for Lundbeck’s Cipralex/Lexapro? I dunno, you tell me, or maybe you could ask Brennan McCartney? No sorry, he’s dead, just because his doctor relied on the objectivity of the ‘experts’ advice, believed it, and subsequently prescribed Brennan a sample pack of Cipralex. You can read Brennan’s story here.

Coincidentally, both IFMAD founders, Siegfried Kasper (Austria) and Stuart A. Montgomery (UK), have previously ‘investigated’ Cipralex and both studies have had positive results here and here.

Irish Professor Timothy (Ted) Dinan is one of IFMADs scientific advisors, Again coincidentally, he is also a faculty member of the Lundbeck Institute here and a Lundbeck ‘Brain Explorer’ advisor, here. In fact Timothy et al also recently concluded a Cipralex study, this time in rodents, here. The first line states ‘Despite the clinical prevalence of the antidepressant escitalopram, over 30% of escitalopram-treated patients fail to respond to treatment’. Fairly objective statement you may think? In my opinion, that’s a very deceptive statement and expert spiel at its best. What it is actually saying is that Escitalopram (aka Cipralex/Lexapro) has clinical prevalence over other brands and that it works in almost 70% of cases.

Similarly, most of IFMAD’s scientific advisors (listed here), have participated in Cipralex studies and all (without exception) concluded positive results. Here’s a couple of examples: Christer Allgulander (Sweden) here, A.C Altamura (Italy) here, Michael Bauer (Germany) here and Naomi Fineberg (UK) here.

Again (Ahem) most likely coincidentally, at least 12 of IFMAD’s scientific advisors are also faculty members of the Lundbeck Institute: Dinan, Altamura, Boyer, Arango, Kennedy, Mendlewicz, Möller,  Papadimitriou, Rihmer, Stein, Vieta and Zohar.

Lars Von Knorring (Sweden) is an IFMAD scientific advisor. He lists Anne-Liis Von Knorring (relationship unknown) as one of his top co-authors here. She was the same professor who was accused of covering up the bad results of Lundbeck’s Celexa (same drug, different story) and actively misleading doctors and the public hereLars also did studies on Citalopram which once again proved positive; one example here.

Maybe I should get a life and forget that my son would be still alive if he didn’t take Citalopram (same drug as Cipralex), prescribed by doctors who believed in the ‘independent’ spiel dished out by ‘independent’ KOP’s (Key Opinion LiarsLeaders)? NO? You know what I think? I think that IFMAD is a Lundbeck creation, created to propagate the ‘independent’ KOP’s subjective pharma-funded belief in Lundbeck drugs. Yes IFMAD, IAM(VERYEFFING)MAD this lovely November morning! Lundbeck-funded propaganda at its worst.

Monte-Carlo (2002) here.

Monte-Carlo (2003) here.

Vienna (2005) here.

Vienna (2006) here.

Budapest (2007) here.

Vienna (2008) here.

Monaco (2009) here.

Vienna (2010) here.

Budapest (2011) here.

Barcelona (2012) here.

Monte Carlo (2013) here.

Our story., Random

The non-pursuit of happiness.

Happy womanThe non-pursuit of happiness. “Happiness often sneaks in through a door you didn’t know you left open” John Barrymore.

There you have it, just when I least expect it, it creeps in (uninvited I might add) and smacks me round my gobsmacked gob!

Today was the usual run of the mill day; there I was, for once minding my own business, standing in the kitchen after collecting the kids from school, when it happened. Lucy was rabbiting on about planting her acorn tree in the garden, Henry was doing his usual worrying about his maths homework, when there it was; I realised I was happy, or maybe content is a better description. You could have knocked me down with a feather. Four years and one month since my lovely son died and I was just resigning myself to looking at my miserable face staring back at me from the bathroom mirror, when today my heart felt ‘not quite’ so heavy. Do you know how mind-numbingly boring it is being miserable?

I knew it was coming of course; I tried hard to ignore it, I’m not bloody ready, but lately the sadness was lifting whether I liked it or not. This, of course doesn’t mean that I won’t cry in Tescos or embarrass myself at the motor tax counter ever again, but the endless need to fight Lundbeck, the corrupt medical system and even more corrupt Irish psychiatry was being overridden by walks on the beach, feeding the ducks or teaching the kids how to ride a bike (a seemingly impossible task). It doesn’t make me less sad about the way my son died or the fact that he caused the death of an innocent young man, some things can never be unseen or unheard unfortunately, but I’ve resigned myself to it and understand the circumstances.

I certainly won’t be letting Lundbeck off anytime soon (actually not ever) as my son deserved so much better. I wonder sometimes if Ulf Wiinberg (CEO of1111 Lundbeck) sleeps well at night? Probably, but you can bet your bottom dollar that Shane’s face and all the other victim’s faces must make the odd appearance in the pharmaceutical cesspit that lurks in the furthest recesses of his mind. That reminds me, a new book by Peter Gøtzsche ‘Deadly Medicines and Organised Crime: How big pharma has corrupted healthcare‘ has recently been published. Chapter two is freely available here and deals with SSRI induced suicide. If you can’t face reading the whole chapter, then pages 224-229 deal with Lundbeck corruption which you might find interesting.

Lundbeck’s latest symposium is happening soon in Monaco (November). I see that Professor Tim Dinan from UCC Cork is making an appearance, although the European Medicines Agency assured me that Professor Dinan will not receive any honorarium for his trip to Monaco or any of the other Lundbeck sponsored symposia that I brought to their attention; so no worries on the ‘independence’ of their scientific advisors there. Phew, that’s such a relief!

Anyway, getting back to my original point, somehow I feel that this shift in mood would make Shane the happiest of all. Now I think the ducks are waiting for me.